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“Non esistono condizioni ideali in cui scrivere,  
studiare, lavorare o riflettere, ma è solo la  
volontà, la passione e la testardaggine a  
spingere un uomo a perseguire il proprio  
progetto.”  
Konrad Lorenz (1903-1989), scienziato austriaco.  
 
“There are no ideal conditions to write,  
study, work or think, rather,  
it is just will, passion and stubbornness  
that push a man to pursue  
his own project”.  
Konrad Lorenz (1903-1989), Austrian scientist. 
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Sommario 
 
Molti studi hanno rivelato l'importanza dei mitocondri come organelli cellulari 
significativamente coinvolti nell'insorgenza o nella progressione di malattie 
neurodegenerative, il cui principale fattore di rischio è l’invecchiamento. I protocolli 
attuali per l'isolamento dei mitocondri cerebrali sono stati sviluppati per preservarne la 
vitalità, sacrificando la purezza necessaria per eseguire analisi biochimiche ad alta 
prestazione. Il mio progetto di dottorato si è concentrato sullo sviluppo di una nuova 
procedura, al fine di ottenere una frazione mitocondriale altamente purificata, a partire da 
tessuti congelati post-mortem di corteccia cerebrale umana di soggetti sani. La valutazione 
dell'arricchimento mitocondriale e di altri contaminanti cellulari è stata eseguita 
attraverso diversi saggi enzimatici, analisi di western blot e microscopia elettronica a 
trasmissione. Questi esperimenti di convalida hanno dimostrato la purezza dei mitocondri e 
la loro integrità, nonché la conservazione delle membrane associate ai mitocondri. Il 
processo di invecchiamento cerebrale è ritenuto responsabile della modifica chimica di 
lipidi e di cambiamenti nella composizione lipidica delle membrane cellulari. In questo 
contesto, non esistono studi precedenti sui lipidi di mitocondri cerebrali umani. Pertanto, 
questo nuovo metodo è stato applicato per studiare la composizione lipidica di mitocondri 
puri mediante cromatografia su strato sottile. Inoltre, abbiamo indagato se ci fossero 
cambiamenti correlati all'invecchiamento nella composizione lipidica in questi organelli 
essenziali alla vita e alla morte cellulari, in quanto ciò potrebbe portare a una riduzione 
della funzionalità della membrana mitocondriale stessa.  
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Abstract 
 
Many studies have revealed the importance of mitochondria as cellular organelles 
decisively involved in the onset or progression of neurodegenerative diseases, whose main 
risk factor is aging. Current protocols for brain mitochondria isolation have been 
developed to preserve viability, sacrificing the purity that is required to perform high-
throughput biochemical analyses. My Phd project focused on the development of a new 
procedure to obtain a highly pure mitochondrial fraction starting from post mortem frozen 
tissues of human brain cortex of healthy subjects. The evaluation of mitochondrial 
enrichment and other cellular contaminants has been performed through different enzyme 
assays, western blot analyses and transmission electron microscopy. These validation 
experiments demonstrated the purity of mitochondria and their integrity, as well as the 
preservation of mitochondria-associated membranes. The brain aging process is allegedly 
responsible for chemical modification of lipids and changes in the lipid composition of cell 
membranes. In this scenario, there are no previous studies on human brain mitochondria 
lipids. Thus, this new method has been applied to investigate lipid composition of pure 
mitochondria by means of thin layer chromatography. Furthermore, we investigated if 
there were aging related changes in the lipid composition of these organelles essentials to 
cell life and death, since that could produce an impairment of the membrane function. 
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RNS = reactive nitrogen species 
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1. Introduction 
1.1 The origin of mitochondria 
The discovery of mitochondria occurred in the middle of the nineteenth century 
and, although it derived from the contributions of several scientists, it should be 
attributed to the former who has detected mitochondria, the Swiss anatomist and 
physiologist Rudolf Albert von Kölliker, who described granular structures in 
muscle tissue cells [1]. These structures were then better described by the German 
pathologist Richard Altmann, who observed particular granules in almost all 
cellular types and called them “bioblasts” (life germ) (Fig.1).  
 
 
Figure 1. Histological drawings of “bioblasts” in flight muscle (right) and liver cells (left) 
as described by Altmann [2]. 
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Altmann explained in his book that these “bioblasts” were elementary organisms 
with genetic and metabolic autonomy, suggesting that they could have been 
symbionts as well as the fundamental units of cellular activity [2]. Unfortunately, 
Altmann's theories were not accepted by his colleagues, although in the 1960s the 
American scientist Lynn Margulis Sagan would have resumed his speculations by 
suggesting that mitochondria derived from certain bacteria endocyted by host cells, 
becoming endosymbionts [3].  
Eight years later, thanks to the microscope, the microbiologist Carl Benda noticed 
particular bodies during insect spermatogenesis in both filamentous and granular 
form, so he gave them the current name mitochondrion, referring to the appearance 
of these organelles [4]. Indeed, the etiology of the word “mitochondrion” comes 
from the fusion of two terms in ancient Greek: the words “µἴτος” (mitos) meaning 
thread and “χόνδρος” (chondros) meaning granule.  
1.2 The morphology and structure of mitochondria 
In the 20th century, the knowledge about mitochondria increased exponentially due 
to the advancement of biochemical, genetic and instrumental techniques, such as 
the use of electron microscopy. What do we know now about these intriguing 
organelles? They are present in the cytoplasm of all aerobic eukaryotic cells and 
have a spherical or elongated shape that is nearly the size of a bacterium, being 
correlated both from a structural and an evolutionary point of view [5].  
Mitochondria have a diameter of about 0.5 μm and a length of about 1-2μm, but 
they can reach a size up to 10 μm in length. Their number can vary from only one 
mitochondrion in some unicellular algae to tens of thousands in oocytes but, in 
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most cases, they are on average 500-1000. Their shape and volume may be 
modified due to osmotic and chemical changes, in fact, mitochondria swell and 
contract after metabolic processes or in relation to changes of osmotic pressure in 
the cellular environment [6]. Although the external form of mitochondria is 
variable, their internal structural organization is highly conserved [7].  
Mitochondria move freely in the cytoplasm and tend to thicken where the demand 
for energy is greater (i.e, in fibers muscles surrounding myofibrils or in synapses of 
nervous system). The movement of mitochondria has been recognized as a result of 
intricate interactions between proteins on the outer surface and various components 
of the cytoskeleton, which include actin filaments, microtubules, and intermediate 
filaments [8]. With the advent of the electron microscope it was possible to study 
the ultrastructural organization of mitochondria. It is delimited by a double 
membrane: an external membrane in contact with the cytoplasm and an internal 
membrane that folds over many times and creates layered structures called 
“cristae”. Both membranes have a thickness of about 5-6 nm and delimit a volume 
of about 8-20 nm called compartment or intermembrane space. The internal 
membrane encloses the mitochondrial matrix (Fig. 2).  
The outer membrane is smooth and rather elastic, has a relatively simple 
constitution, with about 50% of lipids and 50% of proteins and with reduced 
transport functions. Its structure is very similar to that of plasma membrane and 
other cellular compartments but, a unlike these, it has a great permeability [9, 10]. 
Indeed, mitochondria contain the voltage-dependent   anion   channel (VDAC) 
(also known as mitochondrial porin), which polymerizes and forms pores (aqueous 
transmembrane channels) in the mitochondrial outer membrane, making it freely 
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permeable to ions and molecules with a molecular weight of less than 5000 Dalton 
[11]. Such permeability is confirmed by the biochemical composition of 
intermembrane space, which is similar to that of cytoplasm.  
The inner membrane is structurally and functionally much more complex than the 
outer membrane. Approximately 80 % consists of proteins and the remaining 20 % 
of lipids [9]. The inner membrane differs from all other cellular membrane systems 
for the absence of cholesterol in its lipid skeleton and for having a high content of 
cardiolipin [12], an acidic phospholipid. Moreover, the inner membrane contains 
most of the enzymes involved in the transport of electrons and oxidative 
phosphorylation, various dehydrogenases and different transport systems that 
catalyze the transfer of substrates, metabolic intermediates and adenyl nucleotides 
between the cytosol and the matrix [9].   
 
Figure 2. Ultrastructural mitochondrial organization. A) Electron micrograph. B) Schematic 
representation (Source: http://book.bionumbers.org/how-big-are-mitochondria/) 
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Little is known about the intermembrane space, but electron microscopy 
demonstrated the presence of contact sites between membranes, thus forming 
contiguous zones between the outer and inner membranes [13]. This space also 
contains proteins, such as cytochrome, that play major roles in mitochondrial 
energetic metabolism and apoptosis [14].   
The matrix is a gel-like material that contains ribosomes, most of the enzymes that 
are responsible for the citric acid cycle reactions and the enzymes involved in fatty 
acid oxidation. Through electron tomography of neuronal mitochondria Perkins 
and colleagues found out that a specific subdomain of the inner membrane called 
“cristae membrane” form invaginations that protrude into matrix space through 
narrow, tubular openings they called “cristae junctions” [15] (Figure 3). The 
attachments of cristae to the inner boundary membrane is not described as 
infoldings but as small tubes with the diameter of 30 nm [16]. This new 
information about the mitochondrial structure can have important functional 
implications: it is assumed that "cristae junctions" can be a barrier to the free 
diffusion of ions and metabolites like ADP (adenosine diphosphate) between the 
intercristal and intermembrane spaces [16]. Moreover, inside the matrix, there are 
several copies of the mitochondrial chromosome.  
The human mitochondrial DNA (mtDNA) is relatively small (16569 bp), circular, 
double-stranded and contains 37 genes coding for two rRNAs, 22 tRNAs and 13 
polypeptides, which are all subunits of enzyme complexes of the oxidative 
phosphorylation system [17]. The other proteins required for the respiratory chain 
are coded by nuclear DNA, which implies a close complementation between the 
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two genetic systems. The mtDNA is transmitted through maternal line, since 
mitochondria are almost exclusively inherited by the zygote from the oocyte [18]. 
 
 
Figure 3. Model of mitochondria based on EM tomography. Mitochondria have three 
distinct compartments separated by two membrane systems. The inner membrane consists 
of two parts, the cristae membranes and the inner boundary membrane. These junctions 
have been proposed to regulate the dynamic distribution of proteins, lipids, and metabolites 
between mitochondrial compartments. A) A surface-rendered view of an isolated liver 
mitochondrion generated from an electron tomographic volume. Scale = 100 nm. (B) A 
model of the crista junction in relation to mitochondrial compartments. Reproduced by 
Yamaguchi et al. 2009 [19]. 
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1.3 Endosymbiosis hypothesis 
About 1.5 billion years ago the very first nucleated cell appeared on the earth. Lynn 
Margulis Sagan proposed that, during the transition to the oxidizing atmosphere, 
eukaryotes originated from the survival of a heterotrophic anaerobe that ingested 
an aerobic prokaryotic microbe [3]. As stated above, this is supported by many 
existing analogies between mitochondria and bacteria. They have similar size and 
both have one single circular chromosome, which retains genes encoding rRNAs, 
tRNAs, proteins involved in redox reactions, and proteins required for 
transcription, translation, and replication [17]. Respiratory chain enzymes are 
present in the membrane of bacteria and in the mitochondrial internal membrane. 
In addition, the bacterial membrane has introflexions (mesosomes) similar to 
mitochondrial cristae. Like bacteria, mitochondria have no histones and their 
ribosomes are sensitive to certain antibiotics such as chloramphenicol [20]. 
Moreover, mitochondria are formed only through binary fission, the form of cell 
division used by bacteria and archaea [21]. Transport proteins called porins are 
found in the outer membranes of mitochondria and as well as in bacterial cell 
membranes [22]. Cardiolipin is found only in the inner mitochondrial membrane 
and bacterial cell membranes [23].  From all these circumstances, it has been 
hypothesized that the inner membrane and the mitochondrial matrix represent the 
symbiont which was originally enveloped by the plasma membrane and embedded 
in the eukaryotic cell. 
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1.4 Mitochondrial Functions 
Mitochondria are involved in many and important cellular processes (Table 1) and 
in particular they play the fundamental function of recovering the energy contained 
in the foods, converting it into chemical energy in the form of ATP (adenosine 
triphosphate). As a matter of fact, despite differing in structure and function in 
different cells, mitochondria are always "closed spaces" where most of the energy 
metabolism takes place [24]. Among scientific milestones, the early studies on cell 
respiration and oxidative phosphorylation were performed by Battelli and Stern, 
who studied biological oxidation [25], and by Warburg who reported that 
respiration was linked to particles [26], later called “grana”, involved in 
strengthening of “respiratory enzymes” [27].  In 1948, Eugene Kennedy and Albert 
Lehninger identified mitochondria as the cell compartment where oxidative 
phosphorylation occurs [28]: this process satisfies about 90 % of the energetic need 
of cells, through the reoxidation of reduced pyridinic and flavinic coenzyme 
(NADH and FADH2 respectively), catalyzed by the redox complexes of respiratory 
chain leading to ATP synthesis.  
Mitochondria functions include other essential metabolic pathways, such as the 
citric acid cycle, fatty acid oxidation, the synthesis and degradation of aminoacids 
(urea cycle), and the synthesis of iron–sulfur clusters and heme. Mitochondria can 
work as temporary calcium deposits considering their ability to store it rapidly; this 
contributes to the overall homeostasis of this ion, which is involved in various 
cellular reactions such as signal transduction. Calcium is imported into the matrix 
through a uniport driven by the membrane potential on the inner membrane and 
released through Na+/Ca2+ transporter or a Ca2+-induced release pathway [29, 30]. 
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Mitochondria therefore function as an intracellular calcium reserve along with the 
endoplasmic reticulum, with which there is close communication [31].  
 
Table 1. Functions of mitochondria (Source: https://universe-review.ca/F11-
monocell11a.htm) 
Moreover, mitochondria are of cardinal relevance not only in maintaining cellular 
life but also in controlling programmed cell death (apoptosis) through complex 
mechanisms that can culminate with the opening of the mitochondrial permeability 
transition pore (MPTP), that it is a transmembrane channel voltage-dependent, 
belonging to the inner membrane. Its irreversible opening causes uncoupling of the 
respiratory chain with loss of the electrochemical gradient, cessation of ATP 
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synthesis, release of mitochondrial proteins from intermembrane space (i.e., 
cytochrome c, Smac / Diablo and AIF), and Ca2+ outflow from the matrix [32]. 
Many of these events favor in turn the opening of the pore causing the 
amplification of the process. The final result is a massive osmotic swelling of the 
mitochondria with subsequent mitochondrial membrane rupture and complete 
depolarization.  
1.4.1 Fusion and fission 
Mitochondrial fusion and fission processes are closely related to major events in 
the apoptosis process. Indeed, in most cell types, mitochondria are organized 
within a network of organelles, but at the beginning of the apoptotic process the 
network tends to fragment [33]. The term mitochondrial fission means the 
breakdown of the mitochondrial network in small isolated organelles. It is a typical 
process that manifests during cell division in order to assure the inheritance of the 
mtDNA. This process also occurs during differentiation in response to changes in 
the cell energy need or to toxic stress. Mitochondrial fission is essential for 
providing the growing and dividing cells with an adequate number of 
mitochondria. The mitochondrial fusion process is needed to maintain the network 
of mitochondria and for the correct functioning of these organelles. Indeed, a 
network densely interconnected, can mitigate the effects of environmental damage 
through the exchange of proteins and lipids with other mitochondria. The fusion-
fission cycle is therefore a balance of two concurrent processes: one redeems the 
damage, while the other eliminates it [34]. 
 
11 
 
1.4.2 The electron transport chain 
Through the electron transport chain, the mitochondria fulfill the ATP cell demand 
by performing oxidative phosphorylation. This process consists of a series of 
electron transporters (complexes), most of which are embedded in the inner 
membrane, containing prosthetic groups able to accept and donate one or two 
electrons. The electron transporters complexes originally described are four; 
Complex I, Complex II, Complex III and Complex IV. Additionally, two moving 
electron carriers are needed: coenzyme Q (CoQ or Q) and cytochrome c (Cyt c).  
 
Figure 5. Representation of complexes embedded in the inner membrane with electron flow 
leading to O2 and production of ATP. (Source: 
https://www.boundless.com/biology/textbooks/boundless-biology-textbook/cellular-
respiration-7/oxidative-phosphorylation-76/electron-transport-chain-362-11588/) 
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Our knowledge on ATP synthesis is mainly based on the hypothesis proposed by 
Peter Mitchell in 1961, in which energy translation occurs through the creation of 
transmembrane protonic gradients associated with electronic transfer: the 
chemiosmotic theory [28]. The outer membrane is permeable, in contrast to the 
internal one, even against small molecules and almost all ions including protons 
(H+); the only chemical species that can cross the membrane are those that possess 
a specific transporter inserted into the membrane itself. These are the key features 
for the creation and maintenance of the protonic gradient. The respiratory chain 
receives electrons coming from different pathways by reducing equivalents 
(NADH and FADH2). Electrons derived from NADH are transferred to Complex I 
and then to CoQ, while those derived from succinate are transferred to FADH2 and 
then to Complex II, hence to CoQ. From CoQ the electrons pass to Complex III, to 
Cyt c, then to Complex IV and finally to molecular oxygen to give H2O (Figure 5). 
The free energy released by the electron flow is coupled to the endoergonic 
transport of protons through the inner mitochondrial membrane. This proton 
transport produces both a chemical gradient (ΔpH) and an electrical gradient (ΔΨ), 
generating a protonic electromotive force that drives the protons from the 
intermembrane space to the matrix; as the inner membrane is impermeable to the 
protons, these, in order to return, must pass through the specific domain F0 of the 
transmembrane channel called ATP synthase (or Complex V). The driving force 
that pushes the protons into the matrix provides the energy required for ATP 
synthesis, catalyzed by the F1 domain of ATP synthase. Part of the ATP is used for 
the mitochondrial needs, but the majority is transported out of the organelle 
through the adeninucleotide transporter (ANT) and used for different cellular 
functions. 
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1.4.3 Reactive oxygen species (ROS) 
Mitochondria are considered the largest source of reactive oxygen species (ROS) 
[35] whose production is inevitable during normal oxidative metabolism and 
increases considerably in pathological conditions [36]. Oxygen is a highly 
oxidizing molecule, so it easily accepts electrons from other molecules, producing 
partially reduced products, known as ROS. Since these species have one or more 
free electrons (free radicals), they are unstable and particularly reactive, so they 
tend to pair the electrons by yielding or receiving an opposite spin electron from 
other molecules, to achieve a stable conformation. These partially reduced species 
can react with other radicals, but also with non-radical organic molecules such as 
carbohydrates, nucleic acids, lipids and proteins, generating a series of chain 
reactions damaging biological systems [37].  
The ROS include superoxide anion (O2.-) and its radical conjugated acid (HO2.); the 
hydroxyl radical (OH.), carbonate (CO3.-), peroxyl (RO2.) and alkoxyl (RO.). Even 
some neutral, non-radical species are considered ROS, among them hydrogen 
peroxide (H2O2), HOCl, reactive aldehydes, singlet oxygen and lipid 
hydroperoxides (LOOH) [38,39]. Similarly, reactive nitrogen species (RNS) 
includes both radical species such as nitrogen monoxide (NO.) and non-radical 
species, such as nitrous acid (HNO2), nitrosyl cation (NO+), nitroxyl anion (NO−), 
dinitrogen trioxide (N2O3), dinitrogen tetraoxide (N2O4), nitronium (nitryl) cation 
(NO2+), organic peroxides (ROOH), aldehydes (HCOR) and peroxynitrite 
(ONOOH) [40].  
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Increased concentration of ROS and reactive nitrogen species (RNS) causes 
"oxidative stress". This phenomenon is the result of a disequilibrium in the 
homeostasis of reactive species: in normal cells, excess ROS or RNS is prevented 
by scavenging systems and by the ability of some of these species (H2O2) to 
permeate the mitochondrial membrane freely in cytosol, where they play 
physiological roles and are detoxified [41].  
The mitochondrial respiratory chain is the main source of reactive oxygen species 
in a cell, particularly superoxide anion. Mitochondrial O2•− production takes place 
at redox-active prosthetic groups within proteins, or when electron carriers such as 
reduced-CoQ are bound to proteins. The kinetic factors favor or prevent the one-
electron reduction of O2 to O2•− , that determine mitochondrial O2•− production [42].  
O2•−  released into the matrix is detoxified by a specific superoxide 
intramitochondrial dismutase (MnSOD), which catalyzes the following reaction: 2 
O2•−  + 2H+ = O2 + H2O2.   Then, the reduction of H2O2, is performed by the enzyme 
glutathione peroxidase, responsible for most detoxification of intracellular 
hydrogen peroxide; the reaction needs glutathione, whose deficiency is associated 
to mitochondrial dysfunction and consequent cell damage [43]. 
1.4 Cardiolipin 
Cardiolipin (CL) is the signature phospholipid of the mitochondria and has a 
pleiotropic function inside the organelle. Its primary function is associated with 
ATP production along with the electron transport chain, suggesting a fundamental 
role in the bioenergetic process. CL interacts with several inner membrane proteins 
and enzymes, acting as a co-factor for optimal activity [44]. Among these, all the 
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electron transport chain complexes and ADP/ATP carrier (AAC) have shown to be 
tightly bound to CL molecules [45-53]. The AAC allows the ATP to pass across 
the inner membrane to intermembrane space, after oxidative phosphorilation. 
Claypool asserted that, although it is unknown how CL facilitates normal AAC 
physiology, the high affinity between AAC and CL is strongly implicated in full 
AAC function [54]. Indeed, Imai and colleagues showed that, in rat brain 
mitochondria, AAC activity requires either CL or phosphatidylglycerol [55]. Alike, 
CL binding to Complex I, or Cytochrome c oxidase, stabilizes all subunits 
interactions to regulate the electron activity of the enzyme [56] and its binding to 
Complex III is required for the enzyme maintenance and stability, as well as its 
functional and structural integrity [57].  
Furthermore, CL is involved in apoptosis process through the interaction with Cyt 
c; CL bound to Cyc c and act as a peroxidase, catalyzing CL peroxidation which is 
required for release of Cyt c during apoptosis [58]. It must be underlined that CL is 
a phospholipid easily susceptible to ROS attack because particularly rich in 
unsaturated fatty acids and because of its location in the inner membrane, near to 
the site of ROS generation [59]. For these reasons, it is easy to perceive how 
oxidative damage may have deleterious effects on mitochondrial function. 
Moreover, Petrosillo and colleagues showed that exogenous added oxidized CL 
sensitized isolated mitochondria to Ca2+-induced MPTP opening and release of 
cytochrome c [60], and also oxidation of endogenous CL resulted in MPTP 
opening [61].  
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1.5 The role of mitochondria in brain aging 
In the central nervous system, the importance of mitochondrial bioenergy lies in 
the fact that neurons require high ATP consumption to perform their functions. The 
loss of the complex dynamic balance of the mitochondria is an alarm bell for 
cellular damage and can drive to cell death. Brain energy metabolism declines with 
age [62], and mitochondria can be involved in cellular mechanisms that can be 
impaired both in physiological and pathological aging, such as chronic 
neurodegenerative diseases of the senile brain [63]. It is well known that brain 
synapses are the core components of the central nervous system: they allow a 
signal (electrical or chemical) to pass from one neuron to another. Mitochondria 
are concentrated in presynaptic terminals by active transport to provide energy 
supply for information transfer [64]. Despite the well documented plasticity of the 
synaptic junction areas, these peculiar zones of the neuronal membrane undergo 
serious deteriorative events during aging. Indeed, Bertoni-Freddari and co-workers 
carried out a morphometric study on the ultrastructural features of synaptic 
mitochondria in cerebellar glomeruli of adult and old patients, and found a 
significant impairment in the mitochondrial dynamic morphology [65].  
1.5.1 The “mitochondrial theory of aging” 
In 1956 the biogerontologist Denham Harman published a theory, known as the 
“free radical theory of aging”, based on the belief that damage by ROS is critical in 
determining life span [66]. When the free radical theory of aging is focused on 
mitochondria, it emerges as the “mitochondrial theory of aging” [67]. As 
mitochondria continue to generate ROS throughout the cell life, a chronic oxidative 
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stress is produced and this phenomenon increases oxidation of mitochondrial 
proteins, lipids and DNA. ROS also inhibits aconitase activity and thereby affects 
the tricarboxylic acid cycle [68]. A proteomic analysis in rat cerebellum showed an 
increased protein nitration during aging [69]. The MnSOD activity is inhibited by 
nitration and, not surprisingly, it decreases linearly in aged mice brain 
mitochondria [70]. This means that, inside mitochondria, a powerful antioxidant 
defense is overwhelmed during aging. Moreover, it should be stressed that the 
brain is highly vulnerable to oxidative damage because of a relative lack of anti-
oxidant enzymes, an abundance of oxidizable substrates like polyunsaturated fatty 
acids, catecholamines, a high content of redox-active transition metals in certain 
brain regions and a high rate of oxygen utilization per gram weight of tissue 
[71,72].  
1.5.2 Oxidative phosphorylation and aging 
Aging can damage oxidative phosphorylation through various mechanisms. For 
example, decreasing the enzymatic activity of one of the electron transport chain 
complexes can slow the oxidative phosphorylation rate. However, the maximum 
enzymatic activity expressed by the complexes of the electron transport chain 
seems to be in excess respect to phosphorylation, so that a 30-50% decrease in its 
activity is necessary to achieve a real reduction in the maximum phosphorylation 
speed [73]. However, disparate experimental systems have shown an impairment of 
electron transfer complexes in old rat brains [74,75] and in old mice brains [76,77].  
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1.5.3 Mutations of the mitochondrial genome 
The accumulation of somatic mtDNA mutations and the subsequent cytoplasmic 
segregation of these mutations have been shown to contribute to aging process in 
human brain areas such as putamen and cortex [78]. Besides, it has been 
demonstrated that brain mtDNA from elderly individuals had a higher aggregate of 
mutations than brain mtDNA from younger individuals. The average aggregate 
mutational burden in elderly subjects was 2 x 10(-4) mutations/bp [79]. The 
mutation mtDNA4977 is a 4,977 bp deletion of the mitochondrial genome usually 
found in patients with Kearns-Sayre disease, a genetic mitochondrial myopathy. 
Through PCR analysis, Soong and co-workers measured in 12 brain regions of 6 
normal adults (humans) the levels of mtDNA4977 and presented interesting data: a 
comparison of the same region between subjects showed an increase of mtDNA4977 
with age. Particularly, the highest levels were in regions characterized by a high 
dopamine metabolism: caudate, putamen and substantia nigra, while cerebellum 
showed no age-related increase [80]. A possible explanation of the elevated rate of 
mutations observed in the mtDNA (much higher than for nuclear DNA) may be 
explained by the fact that mtDNA is highly exposed to ROS: 1) it is located very 
near the inner mitochondrial membrane where ROS are produced, 2) it is not 
excessively condensed or protected by histones and 3) it has limited repair activity. 
1.5.4 Mitophagy  
In order to maintain a proper cellular bioenergetic status, several quality control 
mechanisms are implemented to eliminate damaged or misfolded mitochondrial 
proteins [81]. Malfunctioning organelles can accumulate through aging, and so it is 
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important to entirely degrade damaged mitochondria. In this case, the cell activates 
a mechanism called mitophagy, which is a selective form of macroautophagy, 
fundamental for cellular homeostasis and implicated in several disease [82].  
Various papers have showed that the depolarization of the mitochondrial 
membrane leads to stabilization of PINK1 (PTEN-induced kinase 1), that in turn 
recruits the E3 ubiquitin ligase Parkin to mitochondria which can trigger 
mitophagy [83-85] (Figure 6). Since the PINK1-parkin pathway is known to be 
involved in the hereditary form of Parkinson’s disease [86], alterations in 
mitophagy machinery may be linked to aging and age-related diseases [87]. 
Although the details of this process need to be further investigated, it seems that 
the regulation of mitophagy shares primary steps with the macroautophagy 
pathway, while displaying different regulatory steps specific for mitochondrial 
autophagic turnover [89].  
Nutrient starvation is a well-established mechanism of increased longevity among 
species because it activates autophagy by inhibiting the Insulin/PI3K/TOR 
signalling pathway [90]. The removal of damaged mitochondria through mitophagy 
could be one of the contributing factors of increased life span by caloric restriction. 
Moreover, it has been reported that low levels of ROS act as signal for mitophagy 
[91]. For example, Kirkland and colleagues found that nerve growth factor (NGF)-
deprived rat sympathetic neurons revealed cardiolipin loss and mitochondrial mass 
decline together with increased production of ROS species and increased lipid 
peroxidation. They were able to block peroxidation, loss of cardiolipin, and the 
decrease of mitochondrial mass with the use of antioxidant agents. So they 
suggested that this decline, caused by autophagy of damaged mitochondria, derived 
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from augmentation of ROS production [92]. On the other side, high ROS levels 
mediate p53 activation that induces autophagy inhibition [93] and exhibits 
prooxidative activities that further increase the stress level, leading to cell death 
[94]. 
 
 
Figure 6. Mechanism of PINK1 and parkin-induced mitophagy. (A) If the mitochondrial 
membrane potential is high, PINK1 is imported into mitochondria, proteolytically 
processed and rapidly degraded. (B) If mitochondria are depolarized, PINK1 accumulates 
on the mitochondrial surface, recruits parkin, which ubiquitinates mitochondrial proteins. 
This process is followed by the recruitment of the adaptor protein (p62), which link 
ubiquitinated cargo to the autophagic machinery. The organelle is engulfed by phagophore, 
which mature into autophagosome, fuse with lysosome to form autolysosome, and finally 
digest its content by mitophagy. Reproduced from Exner et al. 2012 [88].  
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1.6 Mitochondria and age-related diseases 
It is interesting to note that brain mitochondrial dysfunctions and oxidative stress 
have a pivotal role in the pathogenesis of both Parkinson’s Disease (PD) and 
Alzheimer’s Disease (AD), although the molecular link between these age-related 
diseases and the physiological brain aging is still obscure [95]. 
1.6.1 Mitochondria involvement in Alzheimer’s Disease 
AD is the most common form of degenerative dementia and begins predominantly 
in the senile age permanently affecting many cognitive faculties [96]. As the 
average life expectancy progressively increases, the proportion of patients affected 
continuously heightens, becoming a priority for public health. There are currently 
no preventive therapies, but only therapeutic interventions to mitigate the 
symptoms. Many factors contribute to the difficulty of the study approach: the lack 
of information on the pathophysiology of the disease, the lack of an animal model 
to study the pathological processes and evaluate the efficacy of therapies, and the 
absence of a definite biomarker for early stage diagnosis [97].  
At histological level AD brain shows a strong protein accumulation: β-amyloid 
peptide (Aβ) is the major component of the extracellular neuritic plaques, while 
hyperphosphorylated tau protein is the major component of intracellular 
neurofibrillary tangles. The molecular events leading to the development of 
sporadic late-onset AD have not been settled. As aging is the greatest risk factor for 
AD, and energy metabolism is reduced, it has been proposed that mitochondrial 
dysfunction could be the primary event that causes Aβ deposition, synaptic 
degeneration, and formation of neurofibrillary tangles [98,99]. In fact, Bubber and 
22 
 
coworkers found in AD brains a significant decrease in the activities of three TCA 
cycle enzymes: pyruvate dehydrogenase complex, isocitrate dehydrogenase and 
alpha-ketoglutarate dehydrogenase complex [100]. Moreover, there is also a 
diminished activity of COX in platelets and hippocampus from AD patients 
compared to controls [101] and an impairment of mitochondrial biogenesis thus 
suggesting and involvement of mitochondrial abnormalities during the disease 
[102]. 
1.6.2 Mitochondria involvement in Parkinson’s disease 
After AD, PD is the most common neurodegenerative disorder in individuals over 
the age of 65. The most common symptoms of the disease are: “resting tremor, 
plastic rigidity, paucity or delayed initiation of movement, slowness and impaired 
postural and righting reflexes” [103]. The fundamental macroscopic 
anatomopathological alteration in PD brain is the loss of pigmented neurons in the 
pars compacta of the substantia nigra with the microscopic presence of inclusion 
bodies called "Lewy bodies" in surviving neurons [104]. PD and parkinsonism 
become clinically appreciated only when about 50-70% of dopaminergic cells is 
lost [105]. This cell loss results in reduced dopaminergic projection to putamen and 
therefore a dysfunction of the basal ganglia [106].  
In the last few decades, mitochondrial dysfunction has been strongly associated 
with PD: indeed, complex I activity was reported to be significantly reduced in 
mitochondria of substantia nigra [107] and in frontal cortex from post mortem 
brain of PD subjects [108]. Besides, Bender and colleagues showed how levels of 
deleted mtDNA were higher in dopaminergic neurons from PD patients in 
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comparison to age-matched controls [109]. Since complex I is considered one of 
the major producer of ROS [110], it is not surprising that dopaminergic neurons, 
which are exposed to a high oxidative burden, are particularly vulnerable to 
mtDNA damages. Looking at familial PD, there are several mutated genes linked 
to mitochondria. PINK 1 and parkin, both described above for their fundamental 
role in mitophagy, are associated with autosomal recessive PD [111,112].  
Additionally, mutations in the DJ-1 gene, encoding a protein whose function is still 
largely unknown, is associated with early onset autosomal recessive PD [113]. 
There is some demonstration that DJ-1 might play a role in preventing cell death as 
antioxidant defense [114], and that its loss leads to reduced mitochondrial 
membrane potential [115]. Furthermore, Irrcher and coworkers reported that DJ-1 
deficient cultured neurons, mouse brain and lymphoblast cells derived from 
patients displayed aberrant mitochondrial morphology, which is a sign of 
perturbation of their dynamic [116]. Finally, mutations in leucine-rich repeat kinase 
2 (LRRK2) gene remain the most common cause of late onset autosomal dominant 
familial PD and some case of sporadic PD [117]. LRRK2 is present mainly in 
cytoplasm, but is also linked to outer mitochondrial membrane, similar to the 
localization of Parkin. In PD, the critical feature of LRRK2 is its enhanced kinase 
activity, so it might be a target of therapeutic intervention [118]. 
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1.7 Human brain lipids 
1.7.1 Lipid composition of human brain 
The primary biological functions of lipids in the body are the following: deposit of 
chemical energy in storage fat (triglycerides), and structural constituents of cell 
membranes. Lipids are the most common biomolecules present in the brain (12 %) 
and account for 50 % of its dry weight [119], suggesting an elemental role. The 
lipid composition of the whole human brain is chiefly formed by: 1) phospholipids 
which include ethanolamine glycerophospholipids (PE), serine 
glycerophospholipids (PS), choline glycerophospholipids (PC), inositol 
glycerophospholipids (PI), glycerol glycerophospholipids (PG), phosphatidic acid 
(PA); 2) sphingolipids (SL), which includes sphingomyelin (SM), ceramide and 
glycolipids (i.e. gangliosides, galactocerebrosides); 3) cholesterol and free fatty 
acids [120]. Table 2 reports the lipid composition of normal human brain tissue, 
displaying differences between gray and white matter (table 2).  
The various glycerophospholipid species, along with cholesterol and sphingolipids, 
represent the greatest components of cell membranes generating the structure and 
fluidity of somatodendritic and axonal membranes of neurons, and also of those of 
the glia and other cell types, as well as various intracellular organelles [121]. 
Glycerophospholipids are a family of amphipathic molecules distributed 
asymmetrically across the plasma membrane and are composed by a polar head 
group with a glycerol backbone and a phosphobase (ethanolamine, inositol, 
choline, etc.), and a non-polar tail group consisting of two fatty acid chains [122]. 
As all membrane possess a typical composition with more or less the same classes 
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of glycerophospholipids, the ratio between these classes and their molecular 
species are unique and provide membranes from different cellular organelles with 
specific characteristics [123].  
Sphingolipids are amphipatic membrane lipids, which share the same double tailed 
hydrophobic moiety, ceramide, responsible for their insertion in the glycerolipid 
bilayer of biological membranes [124].  
 
Table 2. Percentages of total lipid composition distinguished in white and gray matter of 
human brain tissue. Gangliosides could belong to the unidentified species. Reproduced 
from Krafft et al. 2005 [125]. 
Ceramide is composed by a long-chain amino alcohol, known as sphingosine, 
linked via an amide bond with a variable length fatty acid chain. The term 
“sphingosine” is also used to identify uncommon structures with shorter and longer 
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alkyl chain [126]. Sphingomyelin belongs to the group of sphingophospholipids. It 
is composed of a ceramide backbone with a PC residue attached.  
Among glycosphingolipids, the hydrophilic moiety is represented by an 
oligosaccharide chain, whose structure can range from a very simple one, such as 
galactose in galactosylceramide, to a higher degree of complexity such as sialic 
acids (sugar residues containing a carboxyl group) in gangliosides. Due to their 
highly hydrophilic and bulky saccharidic head group, gangliosides have a strong 
polar character and they are present at elevated levels in neurons [127]. Since they 
are heterogeneous molecules, both in the oligosaccharide and ceramide portions, 
gangliosides are classified according to the oligosaccharide sequence and the 
number of sialic acid residues bound to it by an α-glycosidic bond. In the 
Svennerholm classification for brain gangliosides, letter G denotes ganglioside, 
letter M is a mono-sialic acid residue, D is for di- , T for tri- , and Q indicates 
tetrasyalic acid phosphingolipids [128,129]. A number is then assigned to the 
individual compound, which was initially referred, to its migration into a particular 
chromatographic system.  
Cholesterol is a lipid with a unique structure consisting of four linked hydrocarbon 
rings forming the bulky steroid structure. There is a hydrocarbon tail linked to one 
end of the steroid and a hydroxyl group linked to the other end. The hydroxyl 
group is able to form hydrogen bonds with nearby carbonyl oxygen of 
glycerophospholipid and sphingolipid head groups.  
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1.7.2 Lipids functions in human brain 
Neurochemists initially thought that the absence of triglycerides in the brain meant 
that lipids had only a mere structural function in the central nervous system. 
Subsequent studies revealed that non-membrane lipids are also bioactive 
compounds (i.e. steroid hormones and eicosanoids) and, later, that membrane 
lipids, which were previously believed to have only a structural role, also have 
crucial functions in signal transduction across biological membranes [130].  
1.7.2.1 Glycerophospholipids 
In neural membranes, several glycerophospholipids influence the fluidity, 
permeability, balance of hydrophilic and hydrophobic membrane components, 
charge, reactivity to regulate membrane-bound enzyme activity and ion-channels 
[131,132]. Moreover, glycerophospholipids have other crucial functions in brain 
metabolism as second messenger reservoir. After phospholipase stimulation by 
different agonist, such as hormones or neurotransmitter, an intricate signalling 
cascade activates different metabolic pathways. For example, phospholipase A2 
produces arachidonate, eicosanoids and platelet activating factor (PAF) starting 
from PC, PE and PI, while phospolipase C produces diacylglycerol and IP3 starting 
from PI [133]. PAF has many important roles in brain tissue: it is a retrograde 
messenger in memory formation [134], activates protein kinase c, modulates the 
levels of neuropeptides and regulates neuronal differentiation [135]. 
 Glycerophospholipids that contain alk-1-enyl groups are called plasmalogens and 
are major components of the phospholipids of the mammalian brain [136]. 
Plasmalogens may function like a natural antioxidant because their vinyl ether 
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linkages display reactivity with ROS [137] and may be involved in membrane 
fusion during synaptic transmission thanks to the higher capacity of PE 
plasmalogens to form non-lamellar lipid structures [138].  
1.7.2.2 Sphingolipids and cholesterol 
Ceramide is a cell membrane component involved in the neobiosynthesis and 
catabolism of both sphingomyelin and glycosphingolipids [139](Fig. 7). Ceramides 
and other intermediates of sphingolipid metabolism are key players in intracellular 
signaling and are involved in apoptosis, cell senescence, proliferation, cell growth 
and differentiation [140]. The biosynthetic pathway of sphingolipids first leads to 
ceramide, which generates sphingomyelin and glycosphingolipids. The processing 
of these molecules can produce a range of bioactive lipid species which includes 
ceramide-1-phosphate (C1P), ceramide, sphingosine and sphingosine-1-phosphate 
(S1P) [141]. S1P is essential for development of the brain [142], calcium 
homeostasis [143], cellular growth [144], inhibition of apoptosis [145, 146], 
histone modifications [147], and nuclear factor-κB signalling [148]. While S1P and 
C1P have antiapoptotic effects and favour cell survival, the corrispectives 
sphingosine and ceramide are proapoptotic and associated with growth arrest [149, 
150].  
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Figure 7. Schematic biosynthetic pathway of glycosphingolipids. 
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Within the membrane ocean there are lipid structures of elevated cholesterol and 
glycosphingolipid content named “lipid rafts” [151] (Fig. 8). Lipid rafts incorporate 
also different proteins involved in various aspects of nervous system function: a 
variety of receptor systems, such as G protein-coupled receptors [152] and 
neurotransmitter receptors [153, 154]. Acting as signaling platforms, lipid rafts are 
involved in many events in the development and maintenance of neuronal 
functions, as well as in the interactions between neurons and glial cells [155]. In 
addition to provide correct membrane fluidity and permeability, cholesterol and 
sphingolipids can interact with acetylcholine and serotonin receptors through 
typical binding sites located in both their transmembrane helices and the 
extracellular loops. Therefore, these lipids regulate neurotransmitter binding and 
signal transducing functions by altering the conformation of the receptors [156].  
Furthermore, slight variation in membrane cholesterol content can dramatically 
impair the function of nearby proteins [157]. The dysregulation of cholesterol 
metabolism in the brain has been linked to age-associated neurodegenerative 
disorders such as AD. It has been recently reviewed that microRNAs (miRNAs) 
are implicated as novel regulators of cholesterol metabolism in several tissues: 
indeed, ABCA1, an important membrane-associated lipid pump that plays a key 
role in maintaining cholesterol homeostasis, is negatively regulated by miR106b 
[158]. Kim and colleagues have shown that miR-106b significantly decreased 
ABCA1 levels and impaired cellular cholesterol efflux resulting in increasing Aβ 
production and preventing Aβ clearance in neuronal cells [159]. The interaction 
between SM and cholesterol has many important functions within cell 
compartments, such as the recruitment of integral protein to the lipid bilayer and 
the involvement in caveolae formation during endocytosis [160].  
31 
 
 
 
 
 
Figure 8. Schematic structure of plasma membrane (white bilayer) with lipid rafts (blue 
bilayer). This composition results in lateral phase separation and the generation of a liquid-
ordered domain. Cholesterol, sphingomyelin, and gangliosides, are enriched in lipid rafts. 
As shown, Raft 1 and Raft 2 differ in protein and lipid composition. 
Glycosylphosphatidylinositol-anchored proteins (GPI); transmembrane proteins (TM); 
dually acylated proteins (Acyl). Reproduced from Pike 2003 [151]. 
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1.7.2.3 Gangliosides  
Gangliosides play a key role in the formation and stabilization of specific cell lipid 
membrane domains (glycolipids-rich domains) through their oligosaccaridic 
moieties protruding on the outer membrane surface. Acting as modulators of cell 
recognition, signaling and adhesion, gangliosides are considered functional 
molecules of biological relevance [161]. They also have been indicated to be 
present in nuclear membranes, where GM1 modulates intracellular and intranuclear 
calcium homeostasis and the ensuing cellular functions [162].   
An involvement of gangliosides during brain development underline an additional 
tissue-specific task: indeed, the ganglioside pattern sustains a decisive changing 
during neural growth. At the beginning there is a predominance of GD3 and GM3, 
while later in the development there is an increase in more complex gangliosides 
such as GM1, GD1a, GD1b and GT1b [163].  
Glycosphingolipids are also known to play a role in the regulation of axonal 
growth. For example, gangliosides GD1a and GT1b, enriched in axonal rafts, act as 
myelin-associated glycoprotein (MAG) receptors in MAG-induced inhibition of 
axonal growth [164]. 
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1.8 Lipids of mitochondria 
Each cellular organelle has its own distinctive membrane lipid composition, that 
produces a characteristic structure, shape and specific functions [165]. As the 
mitochondria possesses two biochemically different membranes, the complexity of 
their lipid composition can influence structure and morphology. Furthermore, it has 
been reported that mitochondrial membrane lipids support different mitochondrial 
enzyme activities such as voltage-dependent ion channel and respiratory chain 
complexes [166, 167]. The stability of TOM (translocase of the outer membrane) 
and SAM (sorting and assembly machinery) complexes requires the dimeric form 
of CL to correctly import and assembly α-elical and β-barrel proteins, while PE 
maintains the function of TOM only for the biogenesis of β-barrel proteins [168]. 
Kiebish and co-workers recently examined the mouse brain mitochondrial lipidome 
through mass spectrometry. As shown in table 3, the main lipid species represented 
in mitochondria are PE, PC and cholesterol. Next, the signature lipid of 
mitochondria CL, which is enriched in the inner membrane, followed by 
glycerophospholipid minor classes PI, PG, SM, PS, LysoPC and ceramide in traces 
[169].  
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Table 3. Lipid composition of C57BL/6J mouse brain mitochondria. Reproduced from 
Kiebish et al. 2009 [169]. 
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1.9 First steps toward mitochondria isolation 
The first attempt of subcellular fractionation to isolate mitochondria has to be 
attributed to the Nobel Prize Albert Claude, who was engaged from the late 1930s 
in this detailed study [170] basing on the previous procedure of Bensley and Hoerr 
[171]. His contributions introduced the differential centrifugation as fundamental 
tissue fractionation technique [172], as well as the study of chemical composition 
and biochemical activities of the obtained fractions. Moreover, he was the first 
scientist who establish the importance of using an homogenization isotonic 
medium, that would prevent osmotic changes potentially damaging the organelle 
morphology. Claude’s procedure provided four fractions: a heavy fraction of nuclei 
and cell debris, an intermediate fraction consisting of mitochondria, a light fraction 
containing “microsomes” (endoplasmic reticulum fragments) and a soluble 
cytosolic fraction [173]. Few years later, Hogeboom, Schneider, and Palade [174] 
modified Claude's procedure by replacing the isotonic salt solution used as 
homogenization medium with a hypertonic (0.88 M) sucrose solution. This 
substitution eliminated aggregation of the different particles, improving the purity 
of the fractions and the quality of the isolated mitochondria. The homogenization 
medium was further modified [175] by employing isotonic (0.25 M) rather than 
hypertonic sucrose improving the sedimentation of different fractions and also 
avoiding the inhibitory effect of high concentrations of sucrose on certain enzymes. 
This procedure became the routine method for preparing mitochondria. Many steps 
forward have been made since then, in fact the protocols have been developed and 
diversified depending on the specific properties of tissue or cell types involved and 
its successive application.  
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1.9.1. Isolation of mitochondria from brain samples  
Nowadays there are numerous methods for the isolation of mitochondria from 
brain tissue, based on gentle cell breakage, differential centrifugation and disparate 
density gradients [176-184]. Most of these procedures utilize a rapid isolation of 
mitochondria for enzymatic studies, sacrificing their purity for viability required 
for functional (respiration) based studies. On the contrary, the emergence of high-
throughput “omics” technologies demanded an optimization of purity, because 
other contaminants, even in scarce amounts, would affect results of the analyses. 
Therefore, equilibrium centrifugation in density gradients is the preferred technique 
to separate mitochondria from other cell components. The principle on which it is 
based on concerns the differences in densities of single organelles, influenced 
substantially by their different ratios of protein to lipid species. Mitochondrial inner 
membranes consist of 70–80 % of protein and hence tend to have a higher density 
than, for instance, endosomal membranes, which have higher lipid content. The 
most widely used medium for density gradient centrifugation of proteins is sucrose, 
but Percolltm (a colloidal suspension of tiny silica particles coated with 
polyvinylpyrrolidone or PVP) is more frequently used for the isolation of brain 
mitochondria. Indeed, mitochondria from mammalian brain tissues were routinely 
prepared for proteomics by density gradient centrifugation using Percoll [185, 
186]. Finally, there is also a relatively new approach used to isolate functional 
mitochondria from brain tissue, that is based on superparamagnetic microbeads 
conjugated to anti-TOM22 (translocase of outer mitochondrial membrane 22  
homolog) antibody, which specifically bind to mitochondria outer membrane [187, 
188]. 
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 2. Aim of the study 
Mitochondria are the main energy providers of the cell. Many studies have 
demonstrated the importance of mitochondria as cellular organelles decisively 
involved in brain aging mechanisms. Moreover mitochondrial membrane lipids do 
not only have a structural role, but also sustain different mitochondrial enzyme 
activities such as voltage-dependent ion channel and respiratory chain complexes. 
For these reasons, the aim of the project is the investigation of the lipid 
composition of human brain mitochondria and its changes in physiological aging. 
Since information about lipid composition of human brain mitochondria are 
extremely poor, a full characterization needs to be performed first. Furthermore, in 
order to obtain reliable data, mitochondria must be highly purified. Current 
protocols for brain mitochondria isolation are more developed to preserve viability 
at the expense of the purity that is required by detailed biochemical techniques and, 
commonly, they are optimized on mouse or rat brain tissues. To our knowledge, 
protocols for isolation of human brain mitochondria have been developed 
modifying Sims and Anderson isolation protocol of rat brain mitochondria. The 
preliminary step of this study was the application of this method to isolate 
mitochondria from post mortem human frontal cortex: since results did not fulfill 
requirements, the first aim of this study was to develop a new satisfying method to 
obtain a highly purified mitochondrial fraction. For this purpose, validating 
biochemical assays such as enzymatic assays had to be defined to assess 
mitochondria purity and integrity, in addition to information obtained by 
transmission electron microscopy. Furthermore, this newly developed method was 
applied for the analysis of  mitochondria lipid molecular species and for the 
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investigation of their age-related changes, thus providing a basis for better 
understanding of their role in this physiological process.   
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3. Materials and methods 
3.1. Materials 
3.1.1. Human samples 
Brain samples were obtained during autopsies of male (n=5) and female (n=2) 
subjects (average age 58 years old) who died without evidence of neuropsychiatric 
and neurodegenerative disorders. Informed consents for using brain samples for 
research purposes were obtained from closest relatives and are stored at the Section 
of Legal Medicine and Insurances, Department of Human Biomedical Sciences for 
Health, University of Milan. Final approval was given by the pathologist executing 
the autopsy. Samples of premotor (frontal) cortex were carefully dissected into 
white and grey matter and then stored at -80°C until use for the isolation of 
mitochondria. All tissues samples were analyzed anonymously.  
3.1.2 Materials 
Sucrose, d-Mannitol, Hepes, Tris(hydroxymethyl)aminomethane, Optipreptm, 
Bovine serum albumin (BSA), Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA), Protease Inhibitor Cocktail (PIC), all reagents to set up 
enzyme assay reactions and solvent systems for thin layer chromatography were 
purchased from Sigma-Aldrich Co. Sodium Hydroxide and 
Ethylenediaminetetraacetic acid disodium (EDTA) were purchased from Carlo 
Erba Reagents. Pure galactosylceramide (GalCer), sulfatides, and lyso PC were 
purchased from Avanti Polar Lipids; phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), 
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sphingomyelin (SM), and phosphatidic acid (PA) were purchased from Sigma-
Aldrich Co. Ceramide, gangliosides (GM3, GM2, GM1, GD3, GD1a, GD1b, 
GT1b, GQ1b), glucosylceramide (GlcCer), and lactosylceramide (LacCer) were 
synthesized or purified in Prof. Prinetti laboratories (Department of Medical 
Biotechnology and Translational Medicine, University of Milan, Segrate Milano, 
Italy). 
3.1.3. Equipment 
Potter-Elvehjem PTFE pestle and glass tube (Sigma-Aldrich Co.). Benchtop 
refrigerated high speed centrifuge Thermo Scientific MR23i with swinging bucket 
rotor (SWM 180.5) and angle fixed rotor (AM 100.13). Ultracentrifuge Optima 
XE-90 (Beckman Coulter) with swinging bucket rotor (SW41Ti Beckman Coulter). 
Centrifuge tubes: 15-ml glass round bottom tubes (Corning cod. 8441), 10/11-ml 
polystyrene conical bottom tubes (Nunc cod. 347856), 13.2-ml Ultra-Clear tubestm 
(Beckman Coulter cod. 344059). Laboratory filters for liquids (Euroclone) with 
vacuum pump. Plastic Petri dishes 60x15mm (Greiner cod.628161). Disposable 
plastic and glass Pasteur pipettes. Adjustable volumetric pipettes: 20µl, 200µl and 
1ml total volume.  
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3.2. Methods 
3.2.1. Reagent setup 
• Mitochondria Isolation Buffer (MIB): 75 mM sucrose, 225 mM d-mannitol, 1 
mM EGTA, 1 mM EDTA, 5 mM HEPES, pH 7.40 in ultra-pure water. The pH 
was adjusted to 7.4 with NaOH. The solution was then filtered and stored at -
20°C for up to 3 months. 
• Optipreptm Diluent (OD): 250mM sucrose, 2mM EGTA, 2mM EDTA, 35mM 
Hepes, pH 7.4 in ultra-pure water. The pH was adjusted to 7.4 with NaOH. The 
solution was then filtered and stored at -20°C for up to 3 months. 
• Optipreptm Diluent 2 (OD2): 75 mM sucrose, 225 mM d-mannitol, 1 mM 
EGTA, 1 mM EDTA, 20 mM HEPES, pH 7.40 in ultra-pure water. The pH 
was adjusted to 7.4 with NaOH. The solution was then filtered and stored at -
20°C for up to 3 months. 
• 20% (vol/vol) Optipreptm solution: 2 ml of OD2 were mixed with 1 ml of 60% 
Optipreptm solution. This solution was freshly prepared and stored on ice. 
• 30% (vol/vol) Optipreptm solution: 1.5 ml of OD2 was mixed with 1.5 ml of 
60% Optipreptm solution. This solution was freshly prepared and stored on ice. 
3.2.2 Isolation Protocol 
Mitochondria were isolated from frozen post-mortem human prefrontal cortex. We 
used exclusively grey matter from premotor cortex since it contains more cell 
bodies, while white matter contains almost exclusively fibers. All equipment and 
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reagents were placed on ice and all the centrifuge steps were executed at 4°C. 
Figure 9 shows a schematic diagram of all the protocol steps.  
 
Figure 9: Diagram of the mitochondria isolation protocol. For explanation see description in 
the text. 
3.2.2.1. Preparation of crude heavy mitochondrial fraction (HMF) 
The preparation of the crude fraction containing heavy mitochondria is 
schematically described as follows. 
• A solution containing 1mg/ml of BSA and 1% (v/v) of PIC was added to 
MIB only before use.  
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• The brain tissue (1g of wet weight tissue) was placed in a small Petri dish. 
• The tissue was transferred into the glass potter and 2 ml of MIB were 
added. 
• The tissue was gently homogenized using 13 up-and-down strokes of a 
glass/Teflon pestle while rotating it.  
• The homogenate was placed in a 10-ml conical bottom centrifuge tube and 
5 ml of MIB were added. The tube was gently mixed by inversion. 
• A sample of 100 µl was collected for subsequent evaluation of total tissue 
enzymes or proteins. 
• The homogenate was centrifuged at 800 x g at 4°C for 5 min using a 
swinging-bucket rotor (SWM 180.5).  The supernatant (S1) was 
withdrawn, without collecting the pellet (P1), and retained on ice.  
• 2 ml of MIB were added to the tube and the pellet (P1) was gently 
resuspended with a plastic Pasteur pipette.  
• The suspension was poured in the pestle and homogenized again with 6 
slow up-and-down strokes. The homogenate was transferred in a new tube 
and fresh 4 ml of MIB were added. 
• The homogenate was centrifuge again at 800 x g at 4°C for 5 min using a 
swinging-bucket rotor (SWM 180.5), the supernatant (S2) was withdrawn 
by suction, without transferring the pellet (P2), and pooled with S1.  
• The pooled supernatants (S1+S2) were centrifuged at 800 x g at 4°C for 10 
min using a swinging-bucket rotor (SWM 180.5). The small pellet (P3) 
formed was the proof that it was necessary to further remove contaminants. 
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• The supernatant (S3) was then collected and centrifuged in a round bottom 
glass tube at 3000 x g at 4°C for 10 min using a fixed angle rotor (AM 
100.13). 
• The supernatant (S4) was transferred into a new tube (B) and the 
mitochondrial pellet (P4) gently resuspended with 1 ml of MIB. Then, 5 ml 
of MIB were added and the suspension poured in a different tube (A).  
• Both tubes were centrifuged at 3000 x g at 4°C for 10 min using a fixed 
angle rotor (AM 100.13). 
• From tube B the supernatant (S5B) was collected and stored separately. 
The pellet (P5B) was resuspended with 1 ml of MIB. From tube A the 
supernatant (S5A) was discarded and the pellet (P5A) resuspended with 
1ml of MIB. Then, P5A and P5B were pooled.  
• About 4 ml of MIB were added to the suspension, which was then 
centrifuged at 3000 x g at 4°C for 10 min using a fixed angle rotor (AM 
100.13). 
• The supernatant (S6) was discarded and the pellet (P6) resuspended with 
1ml of OD.  
3.2.2.2 Fractionation of crude HMF 
The fractionation of the crude HMF obtained is schematically described  as 
follows. 
• In a Ultra-clear centrifuge tube (14x89 mm) 3 ml of 30% Optipreptm 
solution were layered with a glass Pasteur pipette; 3 ml of 20% Optipreptm 
solution were slowly layered above the 30% Optipreptm keeping the tube at 
45 
 
45° and loading the sample by directing the flow onto the wall near the 
surface of the liquid. This procedure generated a sharp interface between 
the 30 % layer and the 20 %. 
• To produce a 15 % solution, 2 ml of OD and 1 ml of Optipreptm 60 % were 
added to the sample. The suspension was gently layer with a glass Pasteur 
pipette on the discontinuous gradient, as described before. The tube was 
then filled with 1 ml of OD.  
• The tube was centrifuged at 50.000 x g (Sw 41Ti rotor) at 4°C for 3 hours 
using slow acceleration and deceleration. This centrifugation redistributed 
the material into three major bands (Fig. 10). 
• The material accumulated on the top of the gradient was removed with a 
plastic Pasteur pipette (Band 1 in Fig. 8), and the pale band at the interface 
between 15% and 20% (Band 2 in Fig. 8) was removed with a glass 
Pasteur pipette. 
• The mitochondrial fraction at the interface between 20% and 30% (Band 3 
in Fig. 8) was removed with a glass Pasteur pipette and poured in a 15 ml 
glass round bottom tube. Then, 5 ml of MIB (without PIC and BSA) were 
added,  gently resuspending the mitochondrial fraction with a plastic 
Pasteur pipette. 
• The tube was centrifuge at 3000 x g at 4°C for 10 min using a fixed angle 
rotor (AM 100.13). 
• The supernatant was discarded and the pellet collected by resuspending it 
with 90µl of MIB.  
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Figure 10: The image shows the typical appearance of a centrifuge tube at the end of the 
density gradient ultracentrifugation step. Purified mitochondria are located in band 3. 
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3.2.3 Enzyme assays 
The activity of all maker enzymes was assayed in the initial homogenate and the 
final mitochondrial fraction. In order to measure mitochondrial enrichment, citrate 
synthase (CS) activity was measured immediately after the isolation procedure, 
adjusting the conditions reported by Morgunov and Srere [189]. The purity of the 
obtained fraction was evaluated assaying the activity of different enzymatic 
markers, as explained hereafter. Lactate dehydrogenase (LDH), as cytosolic 
marker, was estimated in both of these fractions; in fact, LDH provides a measure 
of the contamination by synaptosomes in which cytoplasm is enclosed within a 
membrane. The assay was performed using LDH activity assay kit from Sigma-
Aldrich Co. Moreover, to assess lysosomal and peroxisomal contamination, acid 
phosphatase (AP) activity and catalase (CAT) activity were quantified in the same 
previous fractions through AP assay kit and CAT assay kit respectively, both from 
Sigma-Aldrich Co.  The activities were determined using spectrophotometric 
techniques. The quantification of proteins was carried out after protein 
precipitation, through Lowry’s method [190], using BSA as protein standard. 
3.2.4 Western blotting  
Aliquots of isolated mitochondria and brain homogenates were subjected to freeze-
thaw cycles and sonication. Equal amounts of proteins were heated in reducing 
sample buffer [191] and then loaded onto 1.50 mm thick polyacrylamide mini gels 
(12%) and separated by one-dimensional sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (Mini-PROTEAN® 3 Cell; Bio-Rad Laboratories, Inc., 
Hercules, CA, USA). Prestained protein markers (New England BioLabs Inc., 
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Ipswich, MA, USA) were used as size standards in the electrophoresis. Proteins 
were transferred at 350mA for 3 hours (Mini Trans-Blot® Electrophoretic Transfer 
Cell; Bio-Rad Laboratories, Inc.) to 0.45 µm nitrocellulose membranes (Amersham 
Hybond®-ECL; GE Healthcare Life Science). Ponceau-S staining of membranes 
was performed to check the efficiency of proteins transfer.  For immunoblotting, 
membranes were blocked for 2 hours at room temperature with 5% fatty 
acid/globulin-free bovine serum albumin (Sigma-Aldrich Co.) or 5% skimmed 
milk, depending on the antibody, in phosphate-buffered saline (pH 7.4) with 0.1 % 
Tween® 20 (PBST). Then membranes were incubated overnight at 4°C in the 
primary antibody with PBST. The primary antibodies used to evaluate protein 
expression are: 
• Disulfide Isomerase (PDI) at 1:1000 (Cell Signaling);  
• Histone H3 at 1:2000 (Cell Signaling);  
• GRP75 at1:1000 (Cell Signaling);  
• PYK2 at 1:1000 (Bd Transduction); 
• Paxillin at 1:1000 (Bd Transduction). 
After overnight incubation in primary antibody, the membranes were rinsed three 
times in PBST and incubated in secondary antibody for one hour r.t. in HRP-
conjugated goat anti-rabbit IgG (1:5000) or anti-mouse IgG (1:3000). The blots 
were rinsed thoroughly in PBST and were developed using Pierce SuperSignal 
West Pico chemiluminescent substrate and then exposed to CL-XPosure film 
(Thermo Scientific).  
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3.2.5 Total lipid extraction, phase partitioning and alkali treatment 
Lipids from the lyophilized samples were extracted with 
chloroform/methanol/water 20:10:1 (v/v/v) and subjected to a modified two-phase 
Folch’s partitioning to obtain the aqueous and the organic phases [192]. Briefly, 
1240 μL of the solvent system were added to the lyophilized samples. The samples 
were then mixed, incubated at r.t. for 15 minutes and centrifuged at 16100 g, and 
finally kept at r.t. for 15 minutes. The supernatant was collected as total lipid 
extract and the extraction was repeated again twice by adding the 1550 μL of the 
solvent system to the pellets. The pellets were air dried and resuspended in 1N 
NaOH and incubated overnight at r.t. before being brought to 0.05N NaOH with 
water to allow the determination of the protein content with DC assay (Bio-Rad). 
Aliquots of the total lipid extract were then subjected to phase partitioning adding 
20 % of water by volume. The samples were then mixed, incubated at r.t. for 15 
minutes and centrifuged at 16100 g, and finally kept at r.t. for 15 minutes. The 
aqueous phase were recovered, and chloroform:water 1:1 (v/v) were added to the 
organic phase before mixing the samples, incubated at r.t. for 15 minutes, 
centrifuged at 16100 g, and finally kept at r.t. for 15 minutes. The new aqueous 
phases were recovered and united to the ones previously collected. The aqueous 
phases were dried under N2 flux, and resuspended in water before undergoing 
microdialysis and lyophilization. The organic phases were dried under N2 flux and 
resupended in a known volume of chloroform/methanol 2:1. Aliquots of the 
organic phases were then subjected to alkali treatment to remove 
glycerophospholipids [192]. 
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3.2.6 Thin layer chromatography (TLC) 
To determine endogenous lipid content, the various samples were analyzed by 
monodimensional silica gel high performance TLC using different solvent systems. 
The total lipid extracts were analyzed using chloroform/methanol/0.2% calcium 
chloride 60:35:8 (v/v/v) as a solvent system, the aqueous phases were analyzed 
with chloroform/methanol/0.2% calcium chloride 50:42:11 (v/v/v), whereas the 
organic phases and the methanolyzed organic phases were analyzed using 
chloroform/methanol/water 110:40:6 (v/v/v). The organic phases were also 
analyzed by two-dimensional HPTLC using two different solvent systems: 
chloroform/methanol/water 14:6:1 (v/v/v) for the first separation and 
chloroform/methanol/acetic acid 13:5:2 (v/v/v) for the second separation. The 
cholesterol quantitation was performed using hexane/ethylacetate 3:2 (v/v), 
whereas detection of ceramide was executed with 
hexane/chloroform/acetone/acetic acid 20:70:20:4 (v/v/v/v). After separation, lipids 
were detected either by spraying the TLC plates with different colorimetric 
reagents (anisaldehyde, aniline, Ehrlich’s reagent and phospholipids-reactive) or by 
TLC immunostaining. Identification of lipids after separation and chemical 
detection was assessed by co-migration with lipid standards. 
3.2.7 TLC immunostaining 
Gangliosides were detected by TLC-immunostaining with cholera toxin after 
sialidase treatment. Samples were spotted on a silica gel TLC plate and developed 
in chloroform/methanol/0.2 % calcium chloride (50:42:11, v/v). After evaporation 
of the solvent at room temperature, the plate was dipped three times with a 
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polyisobuthylmethacrylate solution, and air dried for 1 hour before being immersed 
in blocking solution (1 % BSA in 0.1M Tris-HCl pH 8, 0.14M NaCl) for 30 
minutes. The plates were then incubated with 0.12 U/mL sialidase (Sigma-Aldrich 
Co) in 0.05 M acetate buffer, pH 5.4, containing 4mM CaCl2, at r.t. overnight. 
Thereafter the plates were overlaid with cholera toxin B subunit-HRP conjugated 
(1:200, Sigma-Aldrich Co) in phosphate-buffered saline with 1% bovine serum 
albumin at r.t. for 1 h. After few washes, plates were developed using o-
phenylenediamine (OPD)/H2O2 in 0.05 M citrate-phosphate buffer pH 5.0.   
3.2.8 Electron microscopy 
Pellets containing mitochondria were fixed for 2 hours in a mixture of 4 % 
paraformaldehyde and 2 % glutaraldehyde in cacodylate buffer (0.12 M, pH 7.4), 
washed extensively in cacodylate buffer and then post-fixed for 1 hour in 2 % 
OsO4 in cacodylate buffer. Samples were then washed with buffer and dehydrated 
in ethanol, then infiltrated in propylene oxide for 15 minutes and subsequently 
overnight in a mixture of propylene oxide and Epon (1:1). After this infiltration the 
pellet of mitochondria were embedded in Epon and following polymerization (+ 60 
°C for 24 hours) thin sections (80 nm) were prepared using an ultramicrotome 
(Leica Ultracut; Leica Microsystems GmBH, Wien, Austria). These sections were 
stained with saturated uranyl acetate for 5 minutes, washed and then stained with 3 
mM lead citrate for 5 minutes. Finally, the sections were photographed using a 
transmission electron microscope TEM LEO 912 (Advanced Light and Electron 
Microscopy BioImaging Center - San Raffaele Scientific Institute). 
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3.2.9 Statistical analysis 
Statistical significance was determined by Student's t-test, considering the data 
with p <0.05 as significant. The histograms represent the mean values obtained, 
and the bars indicate the standard deviation or standard error of the mean. Enzyme 
assays data were expressed as mean ± SEM. All the means were obtained from 
eight independent experiments with two replicas per assay. Considering that human 
brain samples were used for this study, a limited amount of samples was available 
and then has prevented us to perform a larger number of replicas. GRP75 western 
blot was expressed as mean ± SD and obtained from 3 independent experiments. 
All the values obtained from mitochondrial fractions were averaged and  
normalized on the averaged values obtained from brain homogenates. 
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4. Results 
4.1 Morphological of mitochondria isolated from post mortem 
human brain cortex by using Sims and Anderson protocol  
In order to evaluate the yield of Sims and Anderson method [180], mitochondria 
have been isolated following the same steps starting from post mortem brain tissue. 
The mitochondrial fraction was evaluated through transmission electron 
microscopy to get a rough view of their morphology and to estimate the possible 
contaminations. In figure 11 it is evident that the isolated human post mortem brain 
mitochondria are predominantly enclosed into synaptosomes together with many 
other cell components. Considering this result, which is far from the desired purity 
of mitochondria required for our purpose, the main effort of the study was to 
develop a new method to obtain a highly purified mitochondrial fraction from 
human post mortem tissues. 
  
Figure 11: Representative electron micrograph showing a mitochondrial pellet to display 
the characteristic morphology 
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4.2 Analysis of mitochondria isolated from post mortem human 
brain cortex with the new developed method 
The purity and integrity of the isolated mitochondria were analyzed using different 
techniques, as described below. The total protein content of the mitochondrial 
fraction was 377.06 µg ± 117.96 /g of tissue wet weight (mean ± SD; n= 8), as 
determined by Lowry’s assay. 
4.2.1 Enzymatic assay of mitochondrial fractions 
Firstly, several enzymatic markers were selected for the investigation of 
mitochondrial enrichment and the presence of the major contaminants (Fig.12). 
When normalized to total protein concentrations, CS activity exhibited an increase 
of 4.75 ± 0.33-fold purification (mean ± SEM; n= 8), compared with the value of 
brain homogenates. Regarding contaminants, it can be observed that LDH activity, 
used as a synaptosomal marker, was very low in the final pellets (0.03 ± 0.005-
fold) compared to LDH activity in brain homogenates. Instead, AP activity, used as 
assay for lysosomal contamination, showed a similar value in the enriched 
mitochondria fractions compared to brain homogenates (1.05 ± 0.07-fold). 
Peroxisomal contamination appears to be at low levels since CAT activity was 
sensibly diminished in the final mitochondria pellet: indeed CAT showed a 
purification fold of 0.58 ± 0.18 with respect to whole brain tissue homogenates. 
The evaluation of mitochondrial inner membrane intactness in the final fractions 
was performed by calculating the ratio between the CS activity in absence of a 
detergent buffer (Triton X-100TM) versus the activity in the same mitochondria 
preparation in presence of a detergent buffer. Indeed, the CS enzyme is localized in 
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the mitochondrial matrix and its specific activity would not be correctly measured 
if the CS were not released by the rupture of mitochondrial membranes in presence 
of the detergent. This ratio was estimated to be 29.01 ± 3.65 % (mean ± SEM), thus 
demonstrating that the majority of mitochondria remained intact at the end of the 
protocol. 
 
Figure 12. The histogram shows the mean purification fold values (mean ± SEM) of four 
different markers, normalized over brain homogenates (BH) (red dashed line). * = p value < 
0.05 vs BH; *** = p value < 0.001 vs BH    
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4.2.2 Western blot of mitochondrial fractions 
It was decided to proceed with further analysis using western blots, if no enzymatic 
assays were available. Western blots of isolated mitochondria (Fig. 13) 
demonstrated the absence of nuclear contamination (evaluated by H3 levels), while 
showed presence of the endoplasmic reticulum marker (PDI), which seems to be 
enriched in mitochondrial fractions, suggesting the presence of mitochondria-
associated membranes (MAM). To confirm this hypothesis, some of the samples in 
which PDI was detected, were subjected to a specific analysis of a MAM marker 
(GRP75) by mean of western blot (Fig 14). These experiments showed a 
statistically significant increase of GRP75 (1.57 ± 0.32; mean ± SD; n = 4; p value 
< 0.05 vs BH), thus confirming of a MAM enrichment. Additionally, to verify if 
plasma membrane was absent in our mitochondrial fraction, western blot of two 
focal adhesion proteins were measured (Paxillin and PYK2). Figure 13 shows little 
or no plasma membrane contamination in purified mitochondria (Fig.15). 
 
Figure 13. Western blot analyses of PDI and histone H3 on BH and MF obtained from six 
independent experiments. 
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Figure 14. Western blot analyses of protein GRP75 on BH MF obtained from four 
independent experiments (mean ± SD; n = 4). The histogram shows densitometry analysis 
of mean values. * = p value < 0.05 vs BH 
 
  
Figure 15. Western blot analyses of proteins Paxillin and PYK2 on BH and MF, obtained 
from two independent experiments. 
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4.2.3 Transmission electron microscopy of mitochondrial fractions 
Evaluation of ultrastructure of the isolated mitochondria is presented in Fig. 16 
(panels A, B). The presence of intact mitochondrial membranes demonstrated that 
the mitochondrial isolation procedure did not rupture or displace the membranes. 
Moreover, as it can be noticed from panel C (Fig.16), mitochondrial membranes 
bind to MAM micro domains, a further evidence of their presence in isolated 
mitochondria as demonstrated by western blots of typical MAM markers.  
 
Figure 16. Representative electron micrographs showing the morphology of isolated 
mitochondria. These mitochondria were isolated from premotor cortex of a healthy subject 
(51 y.o.). Asterisks mark MAM vesicles juxtaposed to mitochondrial membranes. (Scale 
bar = 0.5µm). 
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4.3. Application of the new developed method for mitochondrial 
lipid analyses 
4.3.1 Analysis of mitochondrial total lipid extract 
After total lipid extraction, a relatively small quantity of sample has been analyzed 
after chromatographic run. This pilot experiment allowed us to observe different 
bands positive for anisaldehyde, a reagent for the non-selective detection of lipids 
(Fig.17). In MF, two major bands correspond to PE and PC, while the darker band 
at the beginning of the chromatographic run may be attributed to sucrose and 
mannitol present in MIB. 
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Figure 17. TLC analysis before microdialysis of total lipid extracts from isolated 
mitochondria (mitochondria isolated from a healthy subject of 50 y.o.). MF and MIB were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (40 µg of 
protein) on a silica gel TLC plate. HPTLC was performed using chloroform/methanol/0.2% 
calcium chloride 60:35:8 (v/v/v) as solvent system. The lipids were then revealed using 
anisaldehyde as colorimetric detection.   
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4.3.2 Analysis of mitochondrial organic phase 
A single mitochondria isolation did not produce sufficient amount of sample to 
perform the following analyses, so it was decided to pool multiple preparations and 
process the samples as one. After two-phase partitioning of total lipid extracts, 
samples were subjected to microdialysis to remove contaminating salts and sugars. 
The organic phase was resolved in different lipid classes and stained with two 
reagents, one for general detection of lipids (Fig. 18) and one specific for 
phospholipids (Fig. 19). In the first plate (Fig. 18) MF displays different bands 
corresponding to GalCer, PE, CL, PC, PI, PS and SM. To confirm the presence of 
phospholipids in MF, the second plate was stained for phosphorus detection 
(Fig.18): in this plate, blue specific bands appear corresponding to PE, CL, PC, PI, 
PS and SM. Beside demonstrating a considerable bandwidth for PE and PC, 
indicating a high number of phospholipids species, it should be emphasized the 
presence of CL, the signature phospholipid of mitochondria.  
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Figure 18. TLC analysis after microdialysis of organic phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). Mitochondrial fraction (MF) and mitochondria isolation buffer (MIB) were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (150 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using CHCl3/CH3OH/H2O 
110:40:6 (v/v/v) as solvent system. The lipids were then revealed using anisaldehyde as 
colorimetric detection.   
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Figure 19. TLC analysis after microdialysis of organic phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). MF and MIB were subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 
(v/v/v) and loaded (150 µg of protein) on a silica gel TLC plate. HPTLC was performed 
using CHCl3/CH3OH/H2O 110:40:6 (v/v/v) as solvent system. The lipids were then 
revealed using a spray specific for phosphorus containing lipids as colorimetric detection.   
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4.3.2.1 2D-TLC   
To obtain a better resolution of phospholipids classes, two-dimensional HPTLC 
was performed in two plates (Fig. 20). This approach allowed us to separate all 
spots, and make the CL more visible with respect to mono-dimensional TLC.  
 
Figure 20. 2D-TLC analyses after microdialysis of organic phases from isolated 
mitochondria (9 pooled preparations, mitochondria isolated from healthy subjects with an 
age range 30-77 y.o.). MF were subjected to lipid extraction with CHCl3/CH3OH/H2O 
20:10:1 (v/v/v) and loaded (200 µg of protein) on two a silica gel TLC plates. Two-
dimensional HPTLC were performed using two different solvent systems: 
CHCl3/CH3OH/H2O 14:6:1 (v/v/v) for the first separation and CHCl3/CH3OH/CH3COOH 
13:5:2 (v/v/v) for the second separation. The lipids were then revealed using anisaldehyde 
(panel A) and a spray specific for phosphorus containing lipids (panel B) as colorimetric 
detection.   
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4.3.2.2 Cholesterol quantitation 
A simple method for cholesterol quantitative determination in MF was developed. 
The solvent system was specific for resolving exclusively cholesterol and a set of 
standard samples of known concentration was used to plot a calibration curve (Fig. 
21). Thus, MF was loaded in double (15µg and 25µg) and bands were quantified 
through densitometric analysis. Cholesterol content was estimated to be 64.20 ± 
1.99 nmol/mg of protein (mean ± SD). 
 
Figure 21. TLC analyses after microdialysis of organic phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). MF were subjected to lipid extraction with CHCl3:CH3OH:H2O 20:10:1 (v/v/v) 
and loaded (30 µg of protein) on a silica gel TLC plates, along with a set of cholesterol 
standard samples of known concentration. HPTLC was performed using C6H14/C4H8O2 3:2 
(v/v), and cholesterol was then revealed using anisaldehyde as colorimetric detection. 
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4.3.3 Analysis of mitochondrial methanolyzed organic phases for 
glycolipids detection 
Aliquots of the organic phases were then subjected to alkali treatment to selectively 
remove phospholipids and observe glycolipids. Also in this case we use two 
identical plates sprayed with two different reagents, one for general detection of 
lipids and one specific for glycolipids (Fig.22). In the case of aniline (Fig. 22B), a 
reagent that detects glycolipids by staining them in blue, the analysis revealed the 
presence of faint glycolipid patterns in MF. Then, in order to discriminate between 
GalCer and GlcCer in MF, we used a TLC plate pre-treated with Na2B4O7 (4 %) 
and a specific solvent system. As it can be seen in Fig. 23, GalCer is present in MF. 
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Figure 22. TLC analyses after microdialysis of methanolyzed organic phases from isolated 
mitochondria (9 pooled preparations, mitochondria isolated from healthy subjects with an 
age range 30-77 y.o.). MF were subjected to lipid extraction with CHCl3/CH3OH/H2O 
20:10:1 (v/v/v) and loaded (250 µg of protein) on two a silica gel TLC plates. HPTLC was 
performed using CHCl3/CH3OH/H2O 110:40:6 (v/v/v) as a solvent system. The lipids were 
then revealed using anisaldehyde (panel A) and aniline (panel B) as colorimetric detection.   
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Figure 23. TLC analyses after microdialysis of methanolyzed organic phases from isolated 
mitochondria (9 pooled preparations, mitochondria isolated from healthy subjects with an 
age range 30-77 y.o.). MF were subjected to lipid extraction with CHCl3/CH3OH/H2O 
20:10:1 (v/v/v) and loaded (260 µg of protein) on two a silica gel TLC plates. HPTLC was 
performed using CHCl3/CH3OH/NH3 (2N) 70:30:3 (v/v/v) as a solvent system. The lipids 
were then revealed using and aniline as colorimetric detection. 
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4.3.3.1 Detection of ceramide 
Using a specific solvent system, we evaluated the presence of ceramide molecules 
with different chain-lengths (C-12/-14/-16/-18/-22). As shown in Fig. 24, in MF 
there is no detectable ceramide with any of the aforementioned chain lengths. 
 
Figure 24. TLC analyses after microdialysis of methanolyzed organic phases from isolated 
mitochondria (9 pooled preparations, mitochondria isolated from healthy subjects with an 
age range 30-77 y.o.).  MF were subjected to lipid extraction with CHCl3/CH3OH/H2O 
20:10:1 (v/v/v) and loaded (120 µg of protein) on two a silica gel TLC plates. HPTLC for 
detection of ceramide was executed with C6H14/CHCl3/C3H6O/CH3COOH 20:70:20:4 
(v/v/v/v). The lipids were then revealed using anisaldehyde as colorimetric detection.   
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4.3.4 Analysis of mitochondrial aqueous phases to identify gangliosides 
Following two-phase partitioning, aqueous phases were also spotted on a silica-gel 
TLC plate to obtain a proper separation of gangliosides. In a first attempt, before 
microdyalisis, we could not observe any glycosphingolipid. Indeed, Ehrlich’s 
reagent, that is used to reveal sialic acid, stained only a sucrose/mannitol non 
specific band (Fig. 25) both in MF and MIB.  After microdyalisis, the non specific 
band disappeared from MIB lane and ganglioside patterns were specifically colored 
by Ehrlich’s reagent (Fig. 26), thus demonstrating that microdialysis successfully 
removed sucrose and mannitol.  
4.3.4.1 Immunostaining with Cholera β-toxin to confirm ganglioside 
presence 
To validate that the previous observed bands were actually gangliosides, we 
decided to perform further experiment, using an immunostaining with cholera β-
toxin after sample resolution. This approach, that allows a selective detection of 
gangliosides, corroborates preceding observation of a particular ganglioside pattern 
(Fig. 27), that characterize MF aqueous phases. 
 
 
 
 
 
71 
 
 
 
Figure 25. TLC analysis before microdialysis of aqueous phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). MF and MIB were subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 
(v/v/v) and loaded (150 µg of protein) on a silica gel TLC plate. HPTLC was performed 
using CHCl3/CH3OH/CaCl2 (0.2 %) 50:42:11 (v/v/v) as solvent system. The lipids were 
then revealed using Ehrlich’s reagent as colorimetric detection.   
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Figure 26. TLC analysis after microdialysis of aqueous phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). MF and MIB were subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 
(v/v/v) and loaded (150 µg of protein) on a silica gel TLC plate. HPTLC was performed 
using using CHCl3/CH3OH/CaCl2 (0.2 %) 50:42:11 (v/v/v) as solvent system. The lipids 
were then revealed using Ehrlich’s reagent as colorimetric detection.   
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Figure 27. TLC analysis after microdialysis of aqueous phases from isolated mitochondria 
(9 pooled preparations, mitochondria isolated from healthy subjects with an age range 30-
77 y.o.). Mitochondrial fraction (MF) and mitochondria isolation buffer (MIB) were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (200 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using using 
CHCl3/CH3OH/CaCl2 (0.2 %) 50:42:11 (v/v/v) as solvent system. Gangliosides were 
detected by TLC-immunostaining with cholera toxin after treatment with sialidase. 
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4.4. Mitochondrial lipid analyses in physiological brain aging 
4.4.1 Analysis of mitochondrial organic phases in aging 
After developing a plan to study main lipid classes characterizing previously 
isolated mitochondria, we decided to compare mitochondrial lipid compositions of 
a young subject and of an old subject. We started with organic phases comparison 
(Fig. 28) and noticed a visible decrease of SM, neutral glycolipids and cholesterol 
in the older subject’s MF, while PE and PC remained basically constant. We also 
analyzed phospholipid species (Fig. 29) and, interestingly, we found a different 
pattern between the two subjects. Moreover, we were able to measure cholesterol 
content quantifying bands through densitometric analysis (Fig. 30) obtaining a 
value of 58.81nmol/mg protein in the young subject’s MF and a value of 
32.57nmol/mg protein. This data reveals a substantial loss of cholesterol content in 
mitochondria through human brain aging.   
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Figure 28. TLC analysis after microdialysis of organic phases from mitochondria isolated 
from two different subjects. The MF isolated from two subjects of 18 y.o. and 87 y.o. were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (100 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using CHCl3/CH3OH/H2O 
110:40:6 (v/v/v) as solvent system. The lipids were then revealed using anisaldehyde as 
colorimetric detection.   
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Figure 29. TLC analysis after microdialysis of organic phases from mitochondria isolated 
from two different subjects. The MF isolated from two subjects of 18 y.o. and 87 y.o. were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (150 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using CHCl3/CH3OH/H2O 
110:40:6 (v/v/v) as solvent system. The lipids were then revealed using a spray specific for 
phosphorus containing lipids as colorimetric detection.   
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Figure 30. TLC analysis after microdialysis of organic phases from mitochondria isolated 
from two different subjects. The MF isolated from two subjects of 18 y.o. and 87 y.o. were 
subjected to lipid extraction with CHCl3:CH3OH:H2O 20:10:1 (v/v/v) and loaded (30 µg of 
protein) on a silica gel TLC plates, along with a set of cholesterol standard samples of 
known concentration. HPTLC was performed using C6H14/C4H8O2 3:2 (v/v), and 
cholesterol was then revealed using anisaldehyde as colorimetric detection. 
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4.4.2 Analysis of mitochondrial methanolyzed organic phases for 
glycolipids detection in aging 
A comparison between the two methanolyzed organic phases was performed by 
running two identical plates sprayed with two different reagents (as previously 
explained). Figure 31 highlights a visible decrease in glycolipid classes in the old 
subject’s MF both with anisaldehyde (panel A) and aniline (panel B) (Fig.31) 
reagents.  
4.4.3 Analysis of mitochondrial aqueous phases for gangliosides detection 
in aging 
Aliquots of the aqueous phases were then spotted on two silica-gel TLC plates in 
order to evaluate possible age-related changes in gangliosides components of MF. 
In Figure 32 there is a remarkable difference between MF of different ages, since 
in the older subject no bands were colored (Fig. 32). Furthermore, with TLC 
immunostaining, which is a far more sensitive technique, a similar ganglioside 
pattern can be observed, but a lower content in all gangliosides species (GM1, 
GD1a, GD1b, GT1b, GQ1b) present in the older subject’s MF than in the young 
subject’s MF (Fig. 33).    
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Figure 31. TLC analysis after microdialysis of methanolyzed organic phases from 
mitochondria isolated from two different subjects. The MF isolated from two subjects of 18 
y.o. and 87 y.o. were subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) 
and loaded (150 µg of protein in panel A and 200µg in panel B) on two a silica gel TLC 
plates. HPTLC was performed using CHCl3/CH3OH/H2O 110:40:6 (v/v/v) as a solvent 
system. The lipids were then revealed using anisaldehyde (panel A) and aniline (panel B) 
as colorimetric detection.   
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Figure 32. TLC analysis after microdialysis of aqueous phases from mitochondria isolated 
from two different subjects. The MF isolated from two subjects of 18 y.o. and 87 y.o. were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (170 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using CHCl3/CH3OH/CaCl2 
(0.2 %)  50:42:11 (v/v/v) as solvent system. The lipids were then revealed using Ehrlich’s 
reagent as colorimetric detection.   
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Figure 33. TLC analysis after microdialysis of aqueous phases from mitochondria isolated 
from two different subjects. The MF isolated from two subjects of 18 y.o. and 87 y.o. were 
subjected to lipid extraction with CHCl3/CH3OH/H2O 20:10:1 (v/v/v) and loaded (200 µg 
of protein) on a silica gel TLC plate. HPTLC was performed using CHCl3/CH3OH/CaCl2 
(0.2 %) 50:42:11 (v/v/v) as solvent system. Gangliosides were detected by TLC-
immunostaining with cholera toxin after treatment with sialidase. 
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 5. Discussion 
 
Mitochondria are cytoplasmic lipid-rich organelles delimited by a double 
membrane, with the external side in contact with the cytoplasm and the internal 
side that folds over many times and creates layered structures called “cristae”. 
Mitochondria do not only represent the cellular power plant but they also play a 
key role in other crucial functions, such as the intrinsic pathway of apoptosis. The 
central nervous system requires high ATP consumption to perform its characteristic 
functions, thus the loss of the mitochondria dynamic balance may lead to neuronal 
damage. Their involvement in brain aging is widely acknowledged by numerous 
studies [62, 63]. Indeed, it has been observed that energy metabolism declines with 
age due to decreased activity of the mitochondrial respiratory chain complexes. In 
addition, the mitochondrial theory of aging postulated that mitochondria continue 
to produce reactive oxygen species within the cell and that this process leads to an 
increase in protein and lipid oxidation, and to an accumulation of mtDNA 
mutations [67]. Besides, there is an alteration of mitopagy [87], a selective process 
of macroautophagy that degrades dysfunctional or structurally damaged 
mitochondria. Finally, mitochondria are considered to be involved in cellular 
mechanisms that promote alterations both in physiological and pathological aging, 
such as chronic neurodegenerative diseases of the senile brain [63].  
Mitochondria possesses two biochemically different membrane: the lipid 
components of the inner and outer mitochondrial membranes are not comparable. 
The outer mitochondrial membrane is fluid and contains higher levels of 
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cholesterol and PI. In contrast, the inner mitochondrial membrane is highly folded, 
enriched in PE and contains CL, a component synthesised and restricted to this 
membrane layer [193]. Furthermore, the actual relative ratio of various lipid 
components may vary with the age-related structural and functional changes of 
brain mitochondria [194]. For example, some factors as cholesterol/phospholipids 
molar ratio, phospholipids composition (i.e. CL), degree of fatty acid unsaturation, 
and lipid/protein ratio can affect the membrane fluidity and, consequently, protein 
activities and mitochondria functionality [195]. There is limited knowledge about 
the lipid composition of brain mitochondria compared to other tissues, such as the 
liver and the heart. In particular, the lipid composition of human brain 
mitochondria is poorly characterized. 
To characterize the lipid species within human brain mitochondria and evaluate if 
there are changes in their lipid composition through aging, we firstly had to obtain 
a reproducible and adequate isolation protocol to obtain highly purified 
mitochondria. To the best of our knowledge, present protocols for isolation of 
human brain mitochondria have been developed mainly modifying Sims and 
Anderson isolation protocol of rat brain mitochondria [180]. The preliminary study 
of the project was the application of this method to isolate mitochondria from post 
mortem human brain cortex. Unfortunately, results did not fulfil requirements since 
electron micrographs showed mitochondria encapsulated inside synaptosomes 
(structures formed at the synaptic level during homogenization after opening and 
reclosing of the plasma membrane), which is index of contamination by other cell 
components. Thus, the first aim of this study was to develop a satisfying and 
standardized method to extract highly purified mitochondria from frozen human 
brain cortex. For this purpose, validating biochemical assays such as enzymatic 
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assays had to be defined to assess mitochondria purity and integrity. To measure 
mitochondrial enrichment and integrity, CS was chosen as marker due to its 
localization inside the mitochondrial matrix. Reliable enzymatic assays of possible 
contaminants were then established according to comparable size and density of 
mitochondria. The evaluation of the contamination by synaptosomes, lysosomes 
and peroxisomes was assayed measuring respectively LDH activity, AP activity 
and CAT activity. Once the new protocol was developed, results from CS assays 
showed a 4.75-fold purification. As specific subcellular populations are purified, 
unique markers of these structures should be enriched. The enrichment from the 
total homogenate depends on the proportion of the homogenate occupied by the 
particles. For example, if 20 % of the homogenate is represented by mitochondria, 
as in the case of liver [195], a maximum enrichment of 5-fold is expected. Precise 
data are not available in the relative composition of brain homogenates, but it has 
been reported that isolated mitochondria from rat neurons (primary culture) showed 
a citrate synthase activity increased by 4-fold [197]. Considering these data, it can 
be pointed out that we obtained a satisfying enrichment.  
If we consider contaminations we found, AP showed an activity of 1.05-fold while 
CAT activity was 0.58-fold with respect to whole brain tissue homogenate. Lisman 
and colleagues reported a purification of rat brain lysosomes with 7-10-fold over 
the homogenate [198] while Kovacs and co-workers achieved a peroxisomal 
fraction puriﬁcation at least 40-fold over the original mouse brain homogenate 
[199]. Comparing these values, it can be observed that peroxisomal contamination 
was definitely low, and lysosomes presence may be estimated to about 10 % of our 
mitochondrial fraction. Moreover, since LDH  value was close to zero (0.03-fold), 
a significative synaptosomal contamination can be excluded.  
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When any enzymatic assay was unavailable, contamination from other cell 
components was evaluated by using western blots. Results demonstrated there was 
not nuclear or plasma membrane contamination, but there was an endoplasmic 
reticulum marker which seemed to be enriched in mitochondrial fractions. 
Therefore, we hypothesized that MAM could have been conserved throughout the 
isolation procedure. MAM are dynamic platforms in close apposition between 
mitochondria and endoplasmic reticulum (Fig. 34), that are implicated in 
fundamental cellular processes, such as lipid biosynthesis and transport, Ca2+ 
signalling, energy metabolism, cell survival and apoptosis [31]. Electron 
microscopy results actually showed not only mitochondrial membranes integrity, 
but also the presence of MAM vesicles juxtaposed to mitochondrial membranes. 
To verify our hypothesis, we performed a western blot quantifying GRP75, a 
MAM marker protein that strengthens the functional interaction between the ER 
and mitochondria by forming a ternary bridging complex [200]. Experiments 
showed a statistically significant increase of GRP75 in mitochondrial fractions and 
a confirmation of MAM enrichment.  
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Figure 34. Schematic representation of mammalian MAM with some of the proteins 
localized at the contact site.  GRP75 (blue) bridges the gap between IP3R and VDAC [200]. 
(Source: https://frombenchtobedside.wordpress.com/2014/03/03/introduction-to-
mitochondria-part-1/) 
 
To investigate the lipid composition of highly purified mitochondria, lipid extracts 
were partitioned into organic and aqueous phases. The analysis of organic phases 
performed by HPTLC revealed the prevalence of phospholipids species (PE, PC, 
SM, CL, PI, PS), as previously demonstrated in mitochondria deriving from 
different tissue types [201]. We detected also cholesterol and glycosphingolipids 
such as GalCer and gangliosides, that are generally assumed to be localized 
primarily (approx. 80%) in the plasma membrane [202]. Since we did not find 
reliable information about lipid composition of human brain mitochondria, we 
compared our data to those obtained from mouse brain mitochondria (Tab. 3) and 
noticed that the ratio between various molecules was very similar. Nevertheless, in 
87 
 
this study [169] gangliosides were found only in trace and other glycosphingolipids 
were not detected. Instead, Gillard and co-workers reported a variable subcellular 
localization of glycosphingolipids: interestingly, both anti-GalCer and monoclonal 
antibody A2B5, which binds polysialogangliosides, localized to mitochondria 
[203] in a wide variety of cell types. Moreover, TLC analyses of rat liver 
membranes revealed that gangliosides were present in mitochondria and 
endoplasmic reticulum as well [202]. Indeed, we can assume that the amount of 
gangliosides in our mitochondrial fractions could not be explained by 
contamination by plasma membrane, since our analyses showed no significant 
contamination. Furthermore, total homogenate ganglioside compositions is not 
similar [204], on a percent basis, to the pattern we detected in  aqueous phases. 
Finally, we conducted a pilot study of how mitochondria lipid composition may 
change in human aging, and noticed relevant differences as below explained. 
Indeed, we saw a visible decrease of SM and neutral glycolipids in the older 
subject compared to younger subject. PE and PC remained basically constant, but 
we observed a different phospholipid distribution pattern between the two subjects 
and a substantial loss of cholesterol content in mitochondria through human brain 
aging. It has to be underlined that mitochondrial phospholipids are critical 
throughout the autophagic process, from initiation and phagophore formation to 
elongation and fusion with endolysosomal vesicles [205], so it is convincing that 
the alteration of phospholipids species in brain aging could lead to 
neurodegeneration. Furthermore, it is known that cholesterol plays a key role in 
maintaining the membrane lipid bilayer architecture by regulating the mobility of 
phospholipids [206], and it is important to remark that the cholesterol content in 
human gray matter was reported to decrease in the oldest age group [207]. 
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Consistently with our result, Ruggiero et al. [208] investigated the effect of aging 
on the lipid composition of rat brain mitochondria and found the same decrease in 
cholesterol content.    
Moreover, our data showed that all gangliosides species (GM1, GD1a, GD1b, 
GT1b, GQ1b) displayed a lower bandwidth in the older subject. The study of 
Segler-Stahl et al. [209] demonstrated that ganglioside concentration decreases 
considerably in human brain, but this event could be explained by the loss of 
neurons and deterioration of synapses, which are known to occur in the 
physiological process of human aging [210]. 
The data obtained showed an evident relative biological difference. To confirm the 
results, it is clearly necessary to have a population statistic that needs an increasing 
of the subjects number. 
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6. Conclusions 
Brain aging is a physiological process of structural and functional decay that occurs 
in different areas of the brain, depending on the lifestyle and predisposition of 
individuals. Major changes in the older brain include an important loss of neurons 
and dendritic trees in numerous regions of the cerebral cortex and hippocampus, a 
decrease in the volume of the gray substance, and an increase in ventricular 
volume. This process causes a cognitive decline that is more concerned with 
specific domains, such as visual and verbal memory. In the central nervous system, 
the cellular energy demand is surprisingly high, but as a person ages, his brain 
energy metabolism declines. Mitochondria are lipid-rich organelles involved in 
many and important cellular processes, but they are popularly known as the power 
house of the cell. These intriguing organelles are decisively involved in brain aging 
as well as in the onset or progression of several age-related neurodegenerative 
diseases. Thus, this project aimed to investigate the lipid composition of human 
brain mitochondria and to evaluate their changes in physiological aging, as no 
previous studies had been performed with this purpose. Firstly, in this study a new 
reliable and reproducible protocol has been developed to isolate highly pure 
mitochondria from post mortem human brain cortex; purity and integrity have been 
verified by biochemical assays and electron microscopy. Secondly, this protocol 
has been applied to study the lipid composition of mitochondrial fractions of 
human brain cortex, and finally, preliminary data have shown differences in 
mitochondria lipid composition during aging, suggesting a need of further 
investigation that will be employed by increasing the number of subjects. In 
conclusion, these data would offer a starting point for new studies, that eventually 
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will be used for the development of new pharmaceutical strategies targeted to 
decelerate aging process and prevent neurodegenerative diseases. 
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